We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
- Authors
Askling, J; Baecklund, E; Granath, F; Geborek, P; Fored, M; Backlin, C; Bertilsson, L; Cöster, L; Jacobsson, L T; Lindblad, S; Lysholm, J; Rantapää-Dahlqvist, S; Saxne, T; van Vollenhoven, R; Klareskog, L; Feltelius, N
- Abstract
Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheumatoid arthritis (RA), but the unresolved issue of whether the use of anti-TNF therapy increases the already elevated risk of lymphoma in RA remains a concern.
- Publication
Annals of the rheumatic diseases, 2009, Vol 68, Issue 5, p648
- ISSN
1468-2060
- Publication type
Journal Article
- DOI
10.1136/ard.2007.085852